- About Us
- Disease State
This assay is designed for the detection of anti-CCP3 IgG and IgA antibodies in patient sera, citrated or EDTA plasma. The presence of these antibodies can aid in the diagnosis of rheumatoid arthritis (RA), including RA diagnosed within 2 years of presentation of symptoms.
QUANTA Lite® CCP3.1 Brochure
IVD-In Vitro Diagnostic Use / CE marked
CLIA Complexity: High
Package Size: 10 X 96 wells
Antigen Source: Synthetic peptide
Disease State Application: Rheumatoid Arthritis
Are you in the United States?